SK Capital Has Entered Into Exclusive Negotiations to Acquire LISI Group’s Medical Division

SK Capital enters exclusive talks to acquire Lisi Medical from LISI Group

SK Capital partners with LISI Group to acquire Lisi Medical, enhancing its presence in the life sciences CDMO sector and driving future growth.

SK Capital Has Entered Into Exclusive Negotiations to Acquire LISI Group’s Medical Division

NEW YORK--(BUSINESS WIRE)--Jul 9, 2025-

SK Capital in talks to acquire LISI Group’s Medical division

New York-based SK Capital Partners, which focuses on the specialty materials, ingredients, and life sciences sectors, has entered into exclusive negotiations with LISI Group to acquire LISI Group’s Medical division, through its affiliate. The transaction remains subject to the approval of the competent antitrust authorities, foreign direct investment control authorities and to the information and consultation processes of the relevant employee r…

France: SK Capital in talks to acquire Lisi Group’s medical division - EUROPE SAYS

SK Capital, a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, has entered into exclusive